Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?
Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?
About this item
Full title
Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Vaccine, 2012-05, Vol.30 (23), p.3369-3375
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights ► Q fever vaccination acceptance among patients with cardiovascular disease. ► Exit interviews following Q fever vaccination. ► Vaccination decision-making may differ among socio-demographic subgroups. ► Risk communication strategies should be tailored to specific target groups.
Alternative Titles
Full title
Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1014102510
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1014102510
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2012.03.056
